Personal
Mr. Jia focuses on capital markets, private equity/venture capital investments, corporate finance，mergers and acquisitions, covering new economy and innovative industries such as telecommunications and technology, healthcare and life Sciences, advanced manufacturing，advanced consumption and Fintech. Mr. Jia has accumulated rich experience in the capital market (especially overseas red-chip listing projects) and enjoys a good reputation in the industry. He has cooperated with many first-tier investment banks and intermediaries, and has undertaken dozens of overseas listing, privatization and overseas bond issuance projects on Hong Kong, NASDAQ, New York, Frankfurt, etc., including such landmark projects as the overseas listing of JD.Com, Meituan-Dianping, Lufax, Haier Zhijia, Zai Lab, Atour ,the privatization of Focus Media and the overseas bond issuance of Tencent Music.
Mr. Jia has been recommended by Chambers Global, Chambers Asia Pacific, Chambers Greater China Region, Asian Legal Business, Legal 500, IFLR, and endorsed by IFLR as “2021 Asia Future Leader”.
Work Highlights
Capital Markets:
Overseas listing and issuance
Represented Jingdong and Tencent in their e-commerce business asset and equity swap and strategic cooperation, listing on NASDAQ and renewal and multiple rounds of issuance of registered senior unsecured bonds (Bank of America Merrill Lynch and UBS)
Represented Goldman Sachs, Morgan Stanley and Bank of America Merrill Lynch as underwriters in connection with the listing of Meituan-Dianping on the Main Board of the Hong Kong Exchange
Represented Goldman Sachs, Bank of America, UBS, HSBC and Ping An Securities as underwriters in connection with the listing of Lu Jinshi Holdings on the New York Stock Exchange
Represented NetEase in its secondary listing on the Main Board of Hong Kong (CICC, Credit Suisse and J.P. Morgan)
Represented Zedin Pharmaceuticals in its listing and renewal on NASDAQ (J.P. Morgan, Citi, Freshfields and SVB Leerink) and secondary listing in Hong Kong (Citi, J.P. Morgan and Goldman Sachs)
Represented Deutsche Bank, CICC, JP Morgan and UBS (underwriters) in connection with the D-share issuance (first ever) of Haier Zhijia (listed on the Shanghai Main Board) on the China Europe International Exchange (CEIBS) in Frankfurt
Acted for CICC and JP Morgan (sponsors) in connection with the issuance of H-shares on the Hong Kong Main Board (introductory listing) and the privatization of Haier Electrical Appliances (Hong Kong Main Board)
Acted for Bank of America, Haitong International and UBS (Underwriters) in connection with the dual primary listing of Mingchuangyoupin on the Main Board of Hong Kong
Acted for CICC and HSBC (underwriters) in the introduction of Conch Environmental Protection to the Main Board of Hong Kong
Acted for Trunsun Group in its listing on the Main Board of Hong Kong (Goldman Sachs and CICC)
Represented Goldman Sachs and UBS (underwriters) in connection with the listing of Keji Pharmaceuticals on the Main Board of Hong Kong
Acted for Genting Sun Yiu in its listing on the Main Board of Hong Kong (Goldman Sachs and Merrill Lynch)
Acted for Ocwenview on its listing on the Main Board of Hong Kong (Morgan Stanley and Goldman Sachs)
Acted for Tongcheng Yilong in its listing on the Main Board of Hong Kong (Morgan Stanley, JP Morgan and CMBI)
Represented Goldman Sachs and Standard Chartered (underwriters) in connection with the listing of Hoze Water Purification on the Main Board of Hong Kong
Acted for Yihua Holdings in its listing on the Main Board of Hong Kong (Morgan Stanley and CCB)
Acted for Legend Bio in its listing on NASDAQ (Goldman Sachs, Freshfields and Bank of America)
Represented Citi, Freshfields, Piper Sandler and Wells Fargo (underwriters) in connection with the NASDAQ listing of Ganci Biologics
Represented Ampico Bio in connection with its NASDAQ listing (Xiyuan and Aptar)
Represented Citi, China Renaissance and China Merchants International (underwriters) in connection with the NASDAQ IPO of Garnant Technology
Represented Morgan Stanley and CICC (underwriters) in connection with the NASDAQ IPO of Qingke
Represented Morgan Stanley, Credit Suisse, JPMorgan Chase and CICC (underwriters) in connection with the NASDAQ listing of Yunjie
Represented Huami Technology in its NYSE listing (Credit Suisse, Citi and China Renaissance) and renewal (Morgan Stanley, Credit Suisse and Citi)
Represented Freshfields Bruckhaus Deringer (underwriter) in connection with the Nasdaq listing of Terasic Holdings
Represented Xunlei in its NASDAQ IPO (JPMorgan and Citi) and the restructuring of its business including the sale of Xunlei Look after the IPO
Represented CenturyLink in its listing on NASDAQ (Bank of America Merrill Lynch and Citi) and its post-IPO M&A program, as well as its privatization from NASDAQ and merger with Lily.com
Represented Noah Wealth in its listing on the New York Stock Exchange (JPMorgan Chase and Bank of America Merrill Lynch)
Represented Goldman Sachs and Morgan Stanley (underwriters) in connection with the listing of Huazhu Hotels (Hanting) on the NASDAQ
Overseas bond issuance:
Represented Jingdong Group JD.Com in its offshore offering of USD 1 billion corporate bonds
Represented the underwriters (BofA, JP Morgan, Goldman Sachs and Morgan Stanley, among others) in connection with Tencent Music's issuance of USD 800 million registered senior unsecured bonds
Represented Huarong Shipping Finance Leasing Company Limited in its offshore issuance of USD 300 million corporate bonds and the establishment of an offshore medium-term note program (Standard Chartered and Faba)
Represented Cinda Capital, Haitong International and other investment banks as joint bookrunners in the issuance of USD 220 million offshore bonds by Zhenjiang Transportation Industry Group Co.
Acted for a number of investment banks, including Barclays, as joint bookrunners in connection with the issuance of USD 220 million overseas bonds by Zhenjiang Transportation Industry Group Limited in 2016
Acted for the bookrunners (Banco Internacional de Macau, Bank of China Macau Branch, etc.) in relation to the USD 220 million offshore bond issuance by Xiamen International Trade Holding Group
Acted for Citi (bookrunner) in connection with the issuance of offshore bonds by Meinian Health
Bio can be found here: https://en.zhonglun.com/team/jiahaibo.html
